Quantcast

Latest Schering-Plough Stories

2014-09-12 08:25:01

DUBLIN, Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Animal Health Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Animal health refers to veterinary services intended to prevent animal diseases or treat animals to enhance their quality of life, increase their lifetime, or increase the yield of animal food. The Global Animal Health market covers the following segments: Feed Additives,...

2014-09-06 23:01:05

Global Animal Vaccines Market 2014-2018 and Global Animal Health Market 2014-2018 are new research reports added to Sandlerresearch.org store. Dallas, Texas (PRWEB) September 06, 2014 One of the major emerging trends in this market is an increase in acquisitions. Vendors have been focusing on acquisitions to increase their foothold in the market through increased investments. According to the “Global Animal Vaccines Market 2014-2018” report, one of the main drivers of this market is...

2014-09-05 16:23:12

LAS VEGAS, Sept. 5, 2014 /PRNewswire/ -- Tamarisk Technologies Group, LLC, a technology development company engaged in the development of innovative drug delivery technology, announced last week that it has added Dr. Mel Affrime to the Tamarisk team as Director of Scientific Affairs. "We are excited to have Mel on the Tamarisk team," says Dean Crowell, Executive Director of Tamarisk Technologies Group. "His experience and expertise in global clinical research and development will...

2014-08-26 12:30:05

New technologies on display include antibiotic-free drugs for livestock, stem cell products for bone healing and mobile devices to monitor pet fitness KANSAS CITY, Mo., Aug. 26, 2014 /PRNewswire-USNewswire/ -- The Kansas City Animal Health Corridor is hosting the world's only full-day investment forum for early and mid-stage animal health companies today at the KC Animal Health Investment Forum. Presenting companies, which hail from seven U.S. states and Canada, are seeking $500,000 to $20...

2014-08-14 08:29:19

SAN DIEGO, Aug. 14, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced that Mr. John McCarty has joined Formex as Scientific Advisor and Science Advisory Board Member. Mr. McCarty has over 30 years of experience in drug product development within the pharmaceutical and biotechnology industries. Mr. McCarty has broad expertise in the development of all major dosage forms and is an inventor on over 17 U.S. and foreign...

2014-07-30 08:32:55

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to...

2014-07-23 12:30:34

CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart failure announced adding two industry veterans to its leadership team. Dale Sander has joined as Chief Financial Officer. Dr. Francis Plat will serve in an advisory capacity as Chief Strategy Officer. http://photos.prnewswire.com/prnvar/20131028/DC04442LOGO Mr. Sander has more than 20 years of...

2014-06-02 08:31:38

CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has appointed Roger J. Pomerantz, M.D., F.A.C.P. as its President and Chief Executive Officer. Dr. Pomerantz will also remain as Chairman of the Board of Directors of Seres, where he has served since November of 2013. Dr. Pomerantz brings...

2014-05-29 23:01:30

James Matthew Gould joins RatnerPrestia as Counsel responsible for strategic patent portfolio management, patent due diligence, freedom-to-operate assessments, validity and infringement opinions; client counseling, patent prosecution, tech transfer and licensing. Gould joined after twenty years with Merck & Co./Schering-Plough as Legal Director. Valley Forge, PA (PRWEB) May 29, 2014 RatnerPrestia is pleased to announce that James Matthew Gould has joined their Valley Forge, PA office...

2014-05-20 08:33:00

First Chewable Tablet for Dogs Effective for 12 Weeks* Against Fleas and Ticks SUMMIT, N.J., May 20, 2014 /PRNewswire/ -- Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Food and Drug Administration's approval of BRAVECTO(TM) (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). BRAVECTO is the first and only treatment that has been shown to quickly and effectively kill fleas and multiple tick...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related